Institutional shares held 116 Million
233K calls
457K puts
Total value of holdings $178M
$356K calls
$699K puts
Market Cap $149M
97,169,296 Shares Out.
Institutional ownership 119.54%
# of Institutions 121


Latest Institutional Activity in MRSN

Top Purchases

Q3 2024
Nextech Invest Ag Shares Held: 12.1M ($18.5M)
Q3 2024
Boxer Capital, LLC Shares Held: 1.82M ($2.78M)
Q3 2024
Citadel Advisors LLC Shares Held: 4.41M ($6.75M)
Q3 2024
Verition Fund Management LLC Shares Held: 1.3M ($1.99M)
Q3 2024
Exome Asset Management LLC Shares Held: 1.18M ($1.8M)

Top Sells

Q3 2024
Woodline Partners LP Shares Held: 434K ($663K)
Q3 2024
Renaissance Technologies LLC Shares Held: 493K ($754K)
Q3 2024
Silverarc Capital Management, LLC Shares Held: 1.59M ($2.43M)
Q3 2024
Morgan Stanley Shares Held: 1.36M ($2.09M)
Q3 2024
Schonfeld Strategic Advisors LLC Shares Held: 2.22M ($3.4M)

About MRSN

Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also develops XMT-1660, a B7-H4-targeted Dolasynthen ADC candidate; and XMT-2056, an immunosynthen development candidate. It has a strategic research and development partnerships with Merck KGaA and Asana BioSciences, LLC for the development of ADC product candidates utilizing Fleximer. The company was formerly known as Nanopharma Corp. and changed its name to Mersana Therapeutics, Inc. in November 2005. Mersana Therapeutics, Inc. was incorporated in 2001 and is headquartered in Cambridge, Massachusetts.


Insider Transactions at MRSN

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
602K Shares
From 10 Insiders
Grant, award, or other acquisition 14.9K shares
Exercise of conversion of derivative security 587K shares
Sell / Disposition
8.22M Shares
From 9 Insiders
Other acquisition or disposition 8.04M shares
Open market or private sale 181K shares

Track Institutional and Insider Activities on MRSN

Follow Mersana Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRSN shares.

Notify only if

Insider Trading

Get notified when an Mersana Therapeutics, Inc. insider buys or sells MRSN shares.

Notify only if

News

Receive news related to Mersana Therapeutics, Inc.

Track Activities on MRSN